CHRONIC KIDNEY DISEASE INFLUENCE ON PROGNOSIS AND READMISSION COST IN PATIENTS WITH CHRONIC HEART FAILURE
https://doi.org/10.24884/1561-6274-2010-14-2-51-55
Abstract
THE AIM. To study the effects of chronic kidney disease (CKD) on prognosis, as well as the frequency, duration of hospitalization and direct medical costs on inpatient care for patients with chronic heart failure (CHF). PATIENTS AND METHODS. The study involved 308 patients with CHF (men – 167, women – 141, mean age – 57. ±10.8 years) during observation period of 60 months. The main cause of CHF was the combination of ischemic heart disease and arterial hypertension – in 193 (63%) patients. The first functional class (FC) was diagnosed in 86.2 FC – at 180.3 FC - in 37, 4 FC – in 5 patients. 47 (15.4%) patients had diabetes. RESULTS. CKD with GFR <60 ml/min/1.73 m² was observed in 108 (35.1%) patients with CHF. The presence of CKD has led to an increase in mortality from all the reasons (relative risk 1.7), increase in average annual number of hospital-governmental organizations in one patient with chronic heart failure for any reason (0.9 [CI 95% 0.2-4.2] against 0.7 [CI 95% 0,09-2.5], p <0.02), and in connection with the aggravation of cardiovascular disease - (0.9 [CI 95% 0.6-5.2] against 0.6 [CI 95% 0.1-3.0], p <0.02). In the presence of CKD with GFR <60 ml/min/1, 73 m² cost of hospital treatment of patients with CHF increased by 21%. CONCLUSION. The presence of CHF patients with chronic kidney disease leads to increased mortality from all causes, increases the number of hospitalizations, duration and cost of hospitalizations for all causes in connection with the escalation cardiovascular disease.
About the Authors
E. R. Makeeva
Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
A. M. Shutov
Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
V. A. Serov
Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
O. V. Troshenkina
Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
S. V. Hiteva
Ульяновский государственный университет, г. Ульяновск
Russian Federation
Russian Federation
References
1. Фомин ИВ, Беленков ЮН, Мареев ВЮ. Распростреннесть ХСН в Европейской части Российской Федерации – данные ЭПОХА-ХСН. Журнал сердечная недостаточность 2006; 7(1): 4-7
2. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998;19 (Suppl P):P9-16
3. Jaarsma T, Halfens RJ, Huijer-Abu Saad H. Readmission of older heart failure patients. Prog Cardiovasc Nurs 1996;11(1):15-20
4. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Журнал сердечная недостаточность 2009; 2 (52): 64-106
5. Hillege H, Girbes A, de Kam P et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210
6. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332:563-564
7. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354:997-999
8. Levey AS, Andreoli SP, DuBose T et al. Chronic kidney disease: common, harmful, and treatable—World Kidney Day 2007. J Am Soc Nephrol 2007; 18:374-378
9. Meguid El, Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365:331-340
10. Frank C, Thomas H, Mark M et al. Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease. Circulation 2006;114:1083-1087
11. Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305
12. Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translated to reduction in cardiovascular events in hypertensive patients. Hypertension 2005; 45 (2): 198-202
13. Карпов ЮА, Мареев ВЮ, Чазова ИЕ. Российские программы оценки эффективности лечения фозиноприлом больных с артериальной гипертонией и сердечной недостаточностью. Проект ТРИ Ф (ФЛАГ,ФАСОН,ФАГОТ). Сердечная недостаточность 2003; 4 (5): 261-265
14. Brewster UC, Setaro JF, Perazella MA. The rennin-angiotensin-aldoserone system: Cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003; 326 (1):15-24
15. Kotanco P. Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif 2006; 24(1): 95-99
16. Национальные Рекомендации ВНОК И ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007; 8(1): 4-41
17. Zakai NA, Katz R, Hirsch C et al. A Prospective Study of Anemia Status, Hemoglobin Concentration, and Mortality in an Elderly Cohort. The Cardiovascular Health Study. Arch Intern Med 2005; 165 (19): 2214-2220
18. Caramelo C, Justo S, Gil P. Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae. Rev ESP Cardiol 2007; 60(80): 848-860
19. Kannel W. Epidemiology and prevention of cardiac failure: Framingham Study insights. EUR Heart J 1987; 8 (Suppl F): 23-29
20. Petretta M, Scopacasa F, Fontanella L et al. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure. J Cardiovasc Med (Hagerstown)2007; 8(11): 909-916
21. Smith DH, Gullion CM, Nichols G et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15:1300-1306
22. Gregory DD, Sarnak MJ, Konstam MA et al. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 2003; 92:1300-1305
23. Selby JV, Ray GT, Zhang D et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20:1396-1402
Review
For citations:
Makeeva E.R., Shutov A.M., Serov V.A., Troshenkina O.V., Hiteva S.V. CHRONIC KIDNEY DISEASE INFLUENCE ON PROGNOSIS AND READMISSION COST IN PATIENTS WITH CHRONIC HEART FAILURE. Nephrology (Saint-Petersburg). 2010;14(2):51-55. (In Russ.) https://doi.org/10.24884/1561-6274-2010-14-2-51-55
Views:
476
Email this article 